Mycosis fungoides beginning in childhood and adolescence
References (24)
- et al.
Mycosis fungoides: natural history and aspects of its relationship to other malignant lymphomas
Am J Med
(1963) - et al.
Leu-8 and Leu-9 antigen phenotype: immunologic criteria for the distinction of mycosis fungoides from cutaneous inflammation
J Am Acad Dermatol
(1986) - et al.
Topical carmustine (BCNU) for mycosis fungoides and related disorders: a 10-year experience
J Am Acad Dermatol
(1983) - et al.
Localized epidermotropic reticulosis (Woringer-Kolopp disease)
J Am Acad Dermatol
(1983) Localized epidermotropic reticulosis
J Am Acad Dermatol
(1984)The natural history of parapsoriasis en plaques (chronic superficial dermatitis) and prereticulotic poikiloderma
Br J Dermatol
(1972)- et al.
Mycosis fungoides: survival, prognostic features, response to therapy, and autopsy findings
Medicine
(1972) - et al.
Mycosis fungoides: clinicopathologic relationships, survival, and therapy in 59 patients, with observations on occupation as a new prognostic factor
Cancer
(1980) - et al.
Mycosis fungoides in Norway 1960-80
Acta Derm Venereol (Stockh)
(1983)
Circulating Sézary cells: a new preparatory method for their identification and enumeration
Arch Pathol Lab Med
Report of the committee on staging and classification of cutaneous T-cell lymphomas
Cancer Treat Rep
Cited by (75)
Clinical characteristics and long-term outcome of 223 patients with mycosis fungoides at a single tertiary center in Korea: A 29-year review
2022, Journal of the American Academy of DermatologyCitation Excerpt :In our study, PL-like MF was the most common variant, followed by the classic form in juvenile MF. Of the known total incidence of MF, juvenile MF accounts for 0.5% to 5%.25,26 However, we found 37 patients (16.6%) with juvenile MF.
Mycosis Fungoides in Children and Adolescents: A Series of 23 Cases
2020, Actas Dermo-SifiliograficasCutaneous lymphoma: Kids are not just little people
2016, Clinics in DermatologyCitation Excerpt :The incidence rate of mycosis fungoides is 0.05% per 100,000 persons per year before the age of 20, and only approximately 0.5-5% of all mycosis fungoides cases are diagnosed before 20 years of age.3,13,15 The true incidence, however, may be higher because MF may be underdiagnosed in younger individuals; often in many patients cutaneous lesions appeared in childhood, but the correct diagnosis was made in adulthood.16–18 Geographic and ethnic variations in the incidence rate have also been observed in children.
Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: A case series of 34 patients
2014, Journal of the American Academy of DermatologyCitation Excerpt :Our study revealed similar data, which contrast with the adult MF population where only 5% exhibit a CD8+ phenotype.10 Five of our patients had coexisting conditions with MF as described previously including: lymphomatoid papulosis, folliculotropic MF with mucinosis, granulomatous slack skin, Hodgkin lymphoma, and pityriasis lichenoides et varioliformis acuta.4,6-8,19-27 We also noted vitamin-D insufficiency or deficiency in 85% of tested patients.
Cutaneous infiltrates - lymphomatous and leukemic
2009, Weedon's Skin Pathology: Third EditionPoor prognosis in non-Caucasian patients with early-onset mycosis fungoides
2009, Journal of the American Academy of DermatologyCitation Excerpt :There are few articles examining age or sex with relation to prevalence of MF in AAs or Hispanics. Koch et al10 reviewed patients with onset of symptoms before age 20 years and suggested that MF may be underdiagnosed in younger patients. Only 4% to 20% of patients with MF had onset of symptoms before age 20 years.